Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents–assessment of adverse events in non‐randomised studies
OJ Storebø, N Pedersen, E Ramstad… - Cochrane Database …, 2018 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …
Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review
F Iasevoli, A Barone, EF Buonaguro… - Expert Opinion on …, 2020 - Taylor & Francis
ABSTRACT Introduction Neurodevelopmental disorders (NDDs) are a group of complex and
heterogeneous disorders, caused by the disruption of normal brain development …
heterogeneous disorders, caused by the disruption of normal brain development …
Executive function in XXY: comparison of performance‐based measures and rating scales
J Janusz, C Harrison, C Boada… - American Journal of …, 2020 - Wiley Online Library
Few studies have systematically assessed executive functioning (EF) skills in boys with XXY,
and these are limited by small samples and restricted EF assessment. This study used a …
and these are limited by small samples and restricted EF assessment. This study used a …
Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance
For patients with attention deficit hyperactivity disorder and comorbid conduct-dissocial
disorder, a combination therapy of the psychostimulant methylphenidate and the …
disorder, a combination therapy of the psychostimulant methylphenidate and the …
Acute hyperkinetic movement disorders as a multifactorial pharmacodynamic drug interaction between methylphenidate and risperidone in children and adolescents
M Mohamoud, Q Chen, D Croteau… - Journal of clinical …, 2022 - journals.lww.com
Acute hyperkinetic movement disorders have been reported with the concomitant use of
attention-deficit/hyperactivity disorder (ADHD) stimulants and antipsychotics in children and …
attention-deficit/hyperactivity disorder (ADHD) stimulants and antipsychotics in children and …
Should we continue methylphenidate treatment despite orofacial or extremity dyskinesias?
SY Kazanci, MC Tarakcioglu, L Bulbul… - … Bülteni-Bulletin of …, 2015 - Taylor & Francis
Attention-deficit/hyperactivity disorder (ADHD) is the most common neuropsychiatric disease
affecting 5.3% of school-aged children. Methylphenidate is the primary stimulant, which has …
affecting 5.3% of school-aged children. Methylphenidate is the primary stimulant, which has …